Benzinga - by Lisa Levin, Benzinga Editor. Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to...
FRANKFURT (Reuters) - German biotech firm Morphosys said it would stop its work on drug candidates that have not yet been tested on humans after its 2023 revenue prospects...
Investing.com - Morphosys AG reported on Wednesday second quarter earnings that missed analysts' forecasts and revenue that topped expectations. Morphosys AG announced earnings...
Investing.com - Morphosys AG reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Morphosys AG announced...
FRANKFURT (Reuters) - German drugmaker Morphosys reported a three-fold increase in its quarterly net loss on Wednesday due to higher costs after the acquisition of U.S. cancer...
Investing.com - Morphosys AG reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations. Morphosys AG announced earnings...
Investing.com - Morphosys AG reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Morphosys AG announced...
Investing.com - Morphosys AG reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Morphosys AG announced earnings per...
Investing.com - Morphosys AG reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that topped expectations. Morphosys AG announced earnings...
Investing.com - Morphosys AG reported on Monday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Morphosys AG announced earnings...